Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion type Assertion NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_head.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion description "[The combination of low doses of Peg-IFN plus a fixed dose of ribavirin resulted in a rate of SVR similar to that obtained with higher doses of the drugs in HIV-infected patients and lower than those obtained in non-HIV patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_provenance.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion evidence source_evidence_literature NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_provenance.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion SIO_000772 15090831 NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_provenance.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion wasDerivedFrom befree-2016 NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_provenance.
- NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_assertion wasGeneratedBy ECO_0000203 NP440393.RAnScP38M0HSAwrlHj3joAzZD7Td-JoRh72rUfWDLE4-M130_provenance.